Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Balance Sheets

v3.26.3
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2026
Dec. 31, 2025
Current assets:    
Cash and cash equivalents $ 75,732 $ 39,013
Accounts receivable, net 8,658 6,263
Inventories, net 30,765 27,083
Contract assets 16,303 2,039
Prepaid expenses and other current assets 12,963 5,722
Total current assets 144,421 80,120
Property and equipment, net 23,216 13,094
Equipment subject to operating lease, net 494 1,629
Other assets 84,174 10,505
Total assets 252,305 105,348
Current liabilities:    
Accounts payable 6,440 10,301
Accrued expenses and other current liabilities 7,702 7,915
Debt – current portion 3,261 6,305
Contract liabilities 10,788 9,281
Total current liabilities 28,191 33,802
Long-term debt - less current portion 4,135 24,710
Contingent earnout liabilities (Note 10) 0 1
Warrant liabilities (Note 10) 81 109
Other noncurrent liabilities 82,595 8,570
Total liabilities 115,002 67,192
Commitments and contingencies (Note 13)
Stockholders’ equity:    
Common stock, $0.00001 par value - 500,000,000 shares authorized at September 30, 2026 and December 31, 2025, respectively, 32,260,870 and 24,607,630 shares issued and outstanding as of September 30, 2026 and December 31, 2025, respectively 5 5
Additional paid-in capital 669,049 536,294
Accumulated deficit (531,751) (498,143)
Total stockholders’ equity 137,303 38,156
Total liabilities and stockholders’ equity $ 252,305 $ 105,348